Kalanchoe pinnata (Lam.) Pers. Leaf ethanolic extract exerts selective anticancer activity through ROS-induced apoptotic cell death in human cancer cell lines
The leaves of Kalanchoe pinnata (Lam.) Pers. (K. pinnata), a succulent plant native to tropical regions, are used as a medicinal alternative against cancer in several countries worldwide; however, its therapeutic potential to fight cancer has been little addressed. In this study, we analyzed the phy...
Saved in:
| Published in: | BMC complementary and alternative medicine Vol. 24; no. 1; pp. 269 - 14 |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
England
BioMed Central Ltd
15-07-2024
BioMed Central BMC |
| Subjects: | |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | The leaves of Kalanchoe pinnata (Lam.) Pers. (K. pinnata), a succulent plant native to tropical regions, are used as a medicinal alternative against cancer in several countries worldwide; however, its therapeutic potential to fight cancer has been little addressed. In this study, we analyzed the phytochemical content, antioxidant capacity, and selectivity of K. pinnata leaf ethanolic extract against different human cancer cell lines in vitro.
This study subjected the ethanolic extract to enzymatic assays to quantify the phytochemical content (phenolics, flavonoids, and anthraquinones) and its radical scavenging and iron-reducing capacities. Also, the phytoconstituents and major phenolic compounds present in the extract's subfractions were identified by GC-MS, HPLC, and NMR. Human cancer (MCF-7, PC-3, HT-29) and normal colon (CoN) cell lines were treated with different concentrations of K. pinnata leaf ethanolic extract, and the changes in cell proliferation (sulforhodamine B assay), caspases activity (FITC-VAD-FMK reporter), mitochondrial membrane potential (MMP, rhodamine 123 assay), chromatin condensation/fragmentation (Hoechst 33342 stain), and ROS generation (DCFH
probe assay) were assessed.
The results showed that the K. pinnata leaf ethanolic extract is rich in phytoconstituents with therapeutic potential, including phenols (quercetin and kaempferol), flavonoids, fatty acid esters (34.6% of the total composition), 1- triacontanol and sterols (ergosterol and stigmasterol, 15.4% of the total composition); however, it presents a poor content of antioxidant molecules (IC
= 27.6 mg/mL for H
O
scavenging activity vs. 2.86 mg/mL in the case of Trolox). Notably, the extract inhibited cell proliferation and reduced MMP in all human cell lines tested but showed selectivity for HT-29 colon cancer cells compared to CoN normal cells (SI = 8.4). Furthermore, ROS generation, caspase activity, and chromatin condensation/fragmentation were augmented significantly in cancer-derived cell lines, indicating a selective cytotoxic effect.
These findings reveal that the K. pinnata leaf ethanolic extract contains several bioactive molecules with therapeutic potential, capable of displaying selective cytotoxicity in different human cancer cell lines. |
|---|---|
| AbstractList | The leaves of Kalanchoe pinnata (Lam.) Pers. (K. pinnata), a succulent plant native to tropical regions, are used as a medicinal alternative against cancer in several countries worldwide; however, its therapeutic potential to fight cancer has been little addressed. In this study, we analyzed the phytochemical content, antioxidant capacity, and selectivity of K. pinnata leaf ethanolic extract against different human cancer cell lines in vitro.
This study subjected the ethanolic extract to enzymatic assays to quantify the phytochemical content (phenolics, flavonoids, and anthraquinones) and its radical scavenging and iron-reducing capacities. Also, the phytoconstituents and major phenolic compounds present in the extract's subfractions were identified by GC-MS, HPLC, and NMR. Human cancer (MCF-7, PC-3, HT-29) and normal colon (CoN) cell lines were treated with different concentrations of K. pinnata leaf ethanolic extract, and the changes in cell proliferation (sulforhodamine B assay), caspases activity (FITC-VAD-FMK reporter), mitochondrial membrane potential (MMP, rhodamine 123 assay), chromatin condensation/fragmentation (Hoechst 33342 stain), and ROS generation (DCFH
probe assay) were assessed.
The results showed that the K. pinnata leaf ethanolic extract is rich in phytoconstituents with therapeutic potential, including phenols (quercetin and kaempferol), flavonoids, fatty acid esters (34.6% of the total composition), 1- triacontanol and sterols (ergosterol and stigmasterol, 15.4% of the total composition); however, it presents a poor content of antioxidant molecules (IC
= 27.6 mg/mL for H
O
scavenging activity vs. 2.86 mg/mL in the case of Trolox). Notably, the extract inhibited cell proliferation and reduced MMP in all human cell lines tested but showed selectivity for HT-29 colon cancer cells compared to CoN normal cells (SI = 8.4). Furthermore, ROS generation, caspase activity, and chromatin condensation/fragmentation were augmented significantly in cancer-derived cell lines, indicating a selective cytotoxic effect.
These findings reveal that the K. pinnata leaf ethanolic extract contains several bioactive molecules with therapeutic potential, capable of displaying selective cytotoxicity in different human cancer cell lines. Abstract Background The leaves of Kalanchoe pinnata (Lam.) Pers. (K. pinnata), a succulent plant native to tropical regions, are used as a medicinal alternative against cancer in several countries worldwide; however, its therapeutic potential to fight cancer has been little addressed. In this study, we analyzed the phytochemical content, antioxidant capacity, and selectivity of K. pinnata leaf ethanolic extract against different human cancer cell lines in vitro. Methodology This study subjected the ethanolic extract to enzymatic assays to quantify the phytochemical content (phenolics, flavonoids, and anthraquinones) and its radical scavenging and iron-reducing capacities. Also, the phytoconstituents and major phenolic compounds present in the extract’s subfractions were identified by GC-MS, HPLC, and NMR. Human cancer (MCF-7, PC-3, HT-29) and normal colon (CoN) cell lines were treated with different concentrations of K. pinnata leaf ethanolic extract, and the changes in cell proliferation (sulforhodamine B assay), caspases activity (FITC-VAD-FMK reporter), mitochondrial membrane potential (MMP, rhodamine 123 assay), chromatin condensation/fragmentation (Hoechst 33342 stain), and ROS generation (DCFH2 probe assay) were assessed. Results The results showed that the K. pinnata leaf ethanolic extract is rich in phytoconstituents with therapeutic potential, including phenols (quercetin and kaempferol), flavonoids, fatty acid esters (34.6% of the total composition), 1- triacontanol and sterols (ergosterol and stigmasterol, 15.4% of the total composition); however, it presents a poor content of antioxidant molecules (IC50 = 27.6 mg/mL for H2O2 scavenging activity vs. 2.86 mg/mL in the case of Trolox). Notably, the extract inhibited cell proliferation and reduced MMP in all human cell lines tested but showed selectivity for HT-29 colon cancer cells compared to CoN normal cells (SI = 8.4). Furthermore, ROS generation, caspase activity, and chromatin condensation/fragmentation were augmented significantly in cancer-derived cell lines, indicating a selective cytotoxic effect. Conclusion These findings reveal that the K. pinnata leaf ethanolic extract contains several bioactive molecules with therapeutic potential, capable of displaying selective cytotoxicity in different human cancer cell lines. Background The leaves of Kalanchoe pinnata (Lam.) Pers. (K. pinnata), a succulent plant native to tropical regions, are used as a medicinal alternative against cancer in several countries worldwide; however, its therapeutic potential to fight cancer has been little addressed. In this study, we analyzed the phytochemical content, antioxidant capacity, and selectivity of K. pinnata leaf ethanolic extract against different human cancer cell lines in vitro. Methodology This study subjected the ethanolic extract to enzymatic assays to quantify the phytochemical content (phenolics, flavonoids, and anthraquinones) and its radical scavenging and iron-reducing capacities. Also, the phytoconstituents and major phenolic compounds present in the extract's subfractions were identified by GC-MS, HPLC, and NMR. Human cancer (MCF-7, PC-3, HT-29) and normal colon (CoN) cell lines were treated with different concentrations of K. pinnata leaf ethanolic extract, and the changes in cell proliferation (sulforhodamine B assay), caspases activity (FITC-VAD-FMK reporter), mitochondrial membrane potential (MMP, rhodamine 123 assay), chromatin condensation/fragmentation (Hoechst 33342 stain), and ROS generation (DCFH.sub.2 probe assay) were assessed. Results The results showed that the K. pinnata leaf ethanolic extract is rich in phytoconstituents with therapeutic potential, including phenols (quercetin and kaempferol), flavonoids, fatty acid esters (34.6% of the total composition), 1- triacontanol and sterols (ergosterol and stigmasterol, 15.4% of the total composition); however, it presents a poor content of antioxidant molecules (IC.sub.50 = 27.6 mg/mL for H.sub.2O.sub.2 scavenging activity vs. 2.86 mg/mL in the case of Trolox). Notably, the extract inhibited cell proliferation and reduced MMP in all human cell lines tested but showed selectivity for HT-29 colon cancer cells compared to CoN normal cells (SI = 8.4). Furthermore, ROS generation, caspase activity, and chromatin condensation/fragmentation were augmented significantly in cancer-derived cell lines, indicating a selective cytotoxic effect. Conclusion These findings reveal that the K. pinnata leaf ethanolic extract contains several bioactive molecules with therapeutic potential, capable of displaying selective cytotoxicity in different human cancer cell lines. Keywords: Kalanchoe pinnata, Cancer, Antioxidant, Ethanolic extract, ROS, Apoptosis, Chromatin condensation The leaves of Kalanchoe pinnata (Lam.) Pers. (K. pinnata), a succulent plant native to tropical regions, are used as a medicinal alternative against cancer in several countries worldwide; however, its therapeutic potential to fight cancer has been little addressed. In this study, we analyzed the phytochemical content, antioxidant capacity, and selectivity of K. pinnata leaf ethanolic extract against different human cancer cell lines in vitro. This study subjected the ethanolic extract to enzymatic assays to quantify the phytochemical content (phenolics, flavonoids, and anthraquinones) and its radical scavenging and iron-reducing capacities. Also, the phytoconstituents and major phenolic compounds present in the extract's subfractions were identified by GC-MS, HPLC, and NMR. Human cancer (MCF-7, PC-3, HT-29) and normal colon (CoN) cell lines were treated with different concentrations of K. pinnata leaf ethanolic extract, and the changes in cell proliferation (sulforhodamine B assay), caspases activity (FITC-VAD-FMK reporter), mitochondrial membrane potential (MMP, rhodamine 123 assay), chromatin condensation/fragmentation (Hoechst 33342 stain), and ROS generation (DCFH.sub.2 probe assay) were assessed. The results showed that the K. pinnata leaf ethanolic extract is rich in phytoconstituents with therapeutic potential, including phenols (quercetin and kaempferol), flavonoids, fatty acid esters (34.6% of the total composition), 1- triacontanol and sterols (ergosterol and stigmasterol, 15.4% of the total composition); however, it presents a poor content of antioxidant molecules (IC.sub.50 = 27.6 mg/mL for H.sub.2O.sub.2 scavenging activity vs. 2.86 mg/mL in the case of Trolox). Notably, the extract inhibited cell proliferation and reduced MMP in all human cell lines tested but showed selectivity for HT-29 colon cancer cells compared to CoN normal cells (SI = 8.4). Furthermore, ROS generation, caspase activity, and chromatin condensation/fragmentation were augmented significantly in cancer-derived cell lines, indicating a selective cytotoxic effect. These findings reveal that the K. pinnata leaf ethanolic extract contains several bioactive molecules with therapeutic potential, capable of displaying selective cytotoxicity in different human cancer cell lines. BackgroundThe leaves of Kalanchoe pinnata (Lam.) Pers. (K. pinnata), a succulent plant native to tropical regions, are used as a medicinal alternative against cancer in several countries worldwide; however, its therapeutic potential to fight cancer has been little addressed. In this study, we analyzed the phytochemical content, antioxidant capacity, and selectivity of K. pinnata leaf ethanolic extract against different human cancer cell lines in vitro.MethodologyThis study subjected the ethanolic extract to enzymatic assays to quantify the phytochemical content (phenolics, flavonoids, and anthraquinones) and its radical scavenging and iron-reducing capacities. Also, the phytoconstituents and major phenolic compounds present in the extract’s subfractions were identified by GC-MS, HPLC, and NMR. Human cancer (MCF-7, PC-3, HT-29) and normal colon (CoN) cell lines were treated with different concentrations of K. pinnata leaf ethanolic extract, and the changes in cell proliferation (sulforhodamine B assay), caspases activity (FITC-VAD-FMK reporter), mitochondrial membrane potential (MMP, rhodamine 123 assay), chromatin condensation/fragmentation (Hoechst 33342 stain), and ROS generation (DCFH2 probe assay) were assessed.ResultsThe results showed that the K. pinnata leaf ethanolic extract is rich in phytoconstituents with therapeutic potential, including phenols (quercetin and kaempferol), flavonoids, fatty acid esters (34.6% of the total composition), 1- triacontanol and sterols (ergosterol and stigmasterol, 15.4% of the total composition); however, it presents a poor content of antioxidant molecules (IC50 = 27.6 mg/mL for H2O2 scavenging activity vs. 2.86 mg/mL in the case of Trolox). Notably, the extract inhibited cell proliferation and reduced MMP in all human cell lines tested but showed selectivity for HT-29 colon cancer cells compared to CoN normal cells (SI = 8.4). Furthermore, ROS generation, caspase activity, and chromatin condensation/fragmentation were augmented significantly in cancer-derived cell lines, indicating a selective cytotoxic effect.ConclusionThese findings reveal that the K. pinnata leaf ethanolic extract contains several bioactive molecules with therapeutic potential, capable of displaying selective cytotoxicity in different human cancer cell lines. The leaves of Kalanchoe pinnata (Lam.) Pers. (K. pinnata), a succulent plant native to tropical regions, are used as a medicinal alternative against cancer in several countries worldwide; however, its therapeutic potential to fight cancer has been little addressed. In this study, we analyzed the phytochemical content, antioxidant capacity, and selectivity of K. pinnata leaf ethanolic extract against different human cancer cell lines in vitro.BACKGROUNDThe leaves of Kalanchoe pinnata (Lam.) Pers. (K. pinnata), a succulent plant native to tropical regions, are used as a medicinal alternative against cancer in several countries worldwide; however, its therapeutic potential to fight cancer has been little addressed. In this study, we analyzed the phytochemical content, antioxidant capacity, and selectivity of K. pinnata leaf ethanolic extract against different human cancer cell lines in vitro.This study subjected the ethanolic extract to enzymatic assays to quantify the phytochemical content (phenolics, flavonoids, and anthraquinones) and its radical scavenging and iron-reducing capacities. Also, the phytoconstituents and major phenolic compounds present in the extract's subfractions were identified by GC-MS, HPLC, and NMR. Human cancer (MCF-7, PC-3, HT-29) and normal colon (CoN) cell lines were treated with different concentrations of K. pinnata leaf ethanolic extract, and the changes in cell proliferation (sulforhodamine B assay), caspases activity (FITC-VAD-FMK reporter), mitochondrial membrane potential (MMP, rhodamine 123 assay), chromatin condensation/fragmentation (Hoechst 33342 stain), and ROS generation (DCFH2 probe assay) were assessed.METHODOLOGYThis study subjected the ethanolic extract to enzymatic assays to quantify the phytochemical content (phenolics, flavonoids, and anthraquinones) and its radical scavenging and iron-reducing capacities. Also, the phytoconstituents and major phenolic compounds present in the extract's subfractions were identified by GC-MS, HPLC, and NMR. Human cancer (MCF-7, PC-3, HT-29) and normal colon (CoN) cell lines were treated with different concentrations of K. pinnata leaf ethanolic extract, and the changes in cell proliferation (sulforhodamine B assay), caspases activity (FITC-VAD-FMK reporter), mitochondrial membrane potential (MMP, rhodamine 123 assay), chromatin condensation/fragmentation (Hoechst 33342 stain), and ROS generation (DCFH2 probe assay) were assessed.The results showed that the K. pinnata leaf ethanolic extract is rich in phytoconstituents with therapeutic potential, including phenols (quercetin and kaempferol), flavonoids, fatty acid esters (34.6% of the total composition), 1- triacontanol and sterols (ergosterol and stigmasterol, 15.4% of the total composition); however, it presents a poor content of antioxidant molecules (IC50 = 27.6 mg/mL for H2O2 scavenging activity vs. 2.86 mg/mL in the case of Trolox). Notably, the extract inhibited cell proliferation and reduced MMP in all human cell lines tested but showed selectivity for HT-29 colon cancer cells compared to CoN normal cells (SI = 8.4). Furthermore, ROS generation, caspase activity, and chromatin condensation/fragmentation were augmented significantly in cancer-derived cell lines, indicating a selective cytotoxic effect.RESULTSThe results showed that the K. pinnata leaf ethanolic extract is rich in phytoconstituents with therapeutic potential, including phenols (quercetin and kaempferol), flavonoids, fatty acid esters (34.6% of the total composition), 1- triacontanol and sterols (ergosterol and stigmasterol, 15.4% of the total composition); however, it presents a poor content of antioxidant molecules (IC50 = 27.6 mg/mL for H2O2 scavenging activity vs. 2.86 mg/mL in the case of Trolox). Notably, the extract inhibited cell proliferation and reduced MMP in all human cell lines tested but showed selectivity for HT-29 colon cancer cells compared to CoN normal cells (SI = 8.4). Furthermore, ROS generation, caspase activity, and chromatin condensation/fragmentation were augmented significantly in cancer-derived cell lines, indicating a selective cytotoxic effect.These findings reveal that the K. pinnata leaf ethanolic extract contains several bioactive molecules with therapeutic potential, capable of displaying selective cytotoxicity in different human cancer cell lines.CONCLUSIONThese findings reveal that the K. pinnata leaf ethanolic extract contains several bioactive molecules with therapeutic potential, capable of displaying selective cytotoxicity in different human cancer cell lines. |
| ArticleNumber | 269 |
| Audience | Academic |
| Author | Vera, Waleska Faundes-Gandolfo, Nicolas Madrid, Alejandro Jara-Gutiérrez, Carlos Párraga, Mario Villena, Joan Montenegro, Iván Escobar, Marcela Valenzuela-Valderrama, Manuel |
| Author_xml | – sequence: 1 givenname: Nicolas surname: Faundes-Gandolfo fullname: Faundes-Gandolfo, Nicolas organization: Centro Interdisciplinario de Investigación Biomédica e Ingeniería para la Salud (MEDING), Escuela de Medicina, Facultad de Medicina, Universidad de Valparaíso, Valparaíso, Chile – sequence: 2 givenname: Carlos surname: Jara-Gutiérrez fullname: Jara-Gutiérrez, Carlos organization: Centro Interdisciplinario de Investigación Biomédica e Ingeniería para la Salud (MEDING), Escuela de Kinesiología, Facultad de Medicina, Universidad de Valparaíso, Valparaíso, Chile – sequence: 3 givenname: Mario surname: Párraga fullname: Párraga, Mario organization: Centro Interdisciplinario de Investigación Biomédica e Ingeniería para la Salud (MEDING), Escuela de Medicina, Facultad de Medicina, Universidad de Valparaíso, Valparaíso, Chile – sequence: 4 givenname: Iván surname: Montenegro fullname: Montenegro, Iván organization: Laboratorio de Química de Metabolitos Bioactivos, Escuela de Química y Farmacia, Facultad de Farmacia, Centro de Investigación Farmacopea Chilena, Universidad de Valparaíso, Escuela de Química y Farmacia, Universidad de Valparaíso, Valparaíso, Chile – sequence: 5 givenname: Waleska surname: Vera fullname: Vera, Waleska organization: Laboratorio de Química de Metabolitos Bioactivos, Escuela de Química y Farmacia, Facultad de Farmacia, Centro de Investigación Farmacopea Chilena, Universidad de Valparaíso, Escuela de Química y Farmacia, Universidad de Valparaíso, Valparaíso, Chile – sequence: 6 givenname: Marcela surname: Escobar fullname: Escobar, Marcela organization: Laboratorio de Química de Metabolitos Bioactivos, Escuela de Química y Farmacia, Facultad de Farmacia, Centro de Investigación Farmacopea Chilena, Universidad de Valparaíso, Escuela de Química y Farmacia, Universidad de Valparaíso, Valparaíso, Chile – sequence: 7 givenname: Alejandro surname: Madrid fullname: Madrid, Alejandro organization: Laboratorio de Productos Naturales y Síntesis Orgánica, Departamento de Química, Facultad de Ciencias Naturales y Exactas, Universidad de Playa Ancha, Valparaíso, Chile – sequence: 8 givenname: Manuel surname: Valenzuela-Valderrama fullname: Valenzuela-Valderrama, Manuel email: manuel.valenzuela@ucentral.cl organization: Laboratorio de Microbiología Celular, Facultad de Medicina y Ciencias de la Salud, Universidad Central de Chile, Santiago, Chile. manuel.valenzuela@ucentral.cl – sequence: 9 givenname: Joan surname: Villena fullname: Villena, Joan email: juan.villena@uv.cl organization: Centro Interdisciplinario de Investigación Biomédica e Ingeniería para la Salud (MEDING), Escuela de Medicina, Facultad de Medicina, Universidad de Valparaíso, Valparaíso, Chile. juan.villena@uv.cl |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39010075$$D View this record in MEDLINE/PubMed |
| BookMark | eNptkttq3DAURU1JadI0P9CHIiiU9MFT3WzLTyWEXkIHUnp5FrJ0PFbwSBNJDs3P9FuruXSYKbUNMkf7LKR99vPixHkHRfGS4Bkhon4XCW1xXWLKS8yrBpfNk-KM1jUtm7ohJwf_p8VFjHcYY8oIa1j1rDhlLSYYN9VZ8fuLGpXTgwe0ss6ppNDlXC1nb9FXCHGG5qB6BGlQzo9WI_iVgtIprxBSRBFG0Mk-AFIuWZ1BEJBaV2x6RGkIfloM6Nvt99I6M2kwSK38KvmsRRrGERlQaUDWoWFaKod2hM3WaB3EF8XTXo0RLnbrefHz44cf15_L-e2nm-ureal5U6dS5QdM1fWMAmakNaTN9zWKg-jyh3XHa1bVzBisel61glc9xcQY1VcEcMfOi5st13h1J1fBLlV4lF5ZuSn4sJAq5FOPIAE6wwTHvCUVJ5R20Jqu0VUHFaNam8x6v2Wtpm4JRoPLno1H0OMdZwe58A-SEMqbRtSZcLkjBH8_QUxyaePaFOXAT1EyLPL0CRYiS1__I73zU3DZq6xqCRWtyHPfqxYq38C63q_HuIbKK4EJF1zUTVbN_qPKr4Gl1Tl-vc31o4Y3Bw0DqDEN0Y9Tst7FYyHdCnXwMQbo924QLNdxlts4yxxnuYmzXDe9OvRx3_I3vOwPqvbydA |
| Cites_doi | 10.1016/j.fct.2004.09.003 10.3406/jobot.2006.2006 10.9734/EJMP/2014/5901 10.1111/php.12006 10.1371/journal.pone.0189628 10.1016/j.canlet.2011.08.001 10.1016/j.marpolbul.2018.01.005 10.3390/molecules24122277 10.1016/j.phymed.2011.06.030 10.3892/etm.2015.2536 10.1080/01635581.2020.1795695 10.1002/jcb.21977 10.1136/bmj.329.7475.1156 10.4014/jmb.1511.11054 10.1271/bbb.65.947 10.4067/S0717-97072012000300022 10.1002/tox.22170 10.2741/E651 10.3390/molecules21111441 10.1016/j.canlet.2018.05.038 10.1016/j.jnutbio.2016.12.011 10.3322/caac.21660 10.1007/s11947-012-0998-z 10.3390/ijms19051265 10.1021/np50065a025 10.1158/1940-6207.CAPR-13-0070 10.1016/j.sjbs.2016.01.037 10.3390/ijms19020448 10.1186/1472-6882-12-15 10.1021/ol061873m 10.1142/S0192415X1100955X 10.1002/ptr.5342 10.1007/s13237-022-00405-3 10.1016/j.lfs.2018.07.027 10.1016/j.bbamcr.2016.09.012 10.3892/etm.2013.1285 10.1002/ptr.6227 10.1016/j.canlet.2005.04.021 10.1038/s41598-020-60079-2 10.1002/jlb.47.5.440 10.1007/s12032-010-9603-3 10.3390/molecules26010067 10.1016/j.plaphy.2021.05.023 10.2174/1871520620666200408082026 10.1016/j.biopha.2019.108783 10.1016/S0023-6438(95)80008-5 10.1038/s41598-019-51322-6 10.1055/s-0033-1350646 10.1016/j.foodchem.2012.01.053 10.1007/s10495-022-01735-y 10.1186/s12906-017-1793-1 10.1016/j.biopha.2019.108721 10.1002/jcb.27738 10.3390/metabo9110258 10.1002/jcb.22044 10.1016/0165-7992(93)90012-K 10.1038/nprot.2007.397 10.1042/BSR20190720 10.1016/j.jep.2018.04.038 10.1016/j.drudis.2014.12.006 10.1016/j.drup.2004.01.004 10.1186/1746-4269-2-45 10.1016/j.freeradbiomed.2010.12.034 10.3390/molecules28145574 10.1038/s41580-018-0089-8 10.1016/S1995-7645(13)60067-X 10.1093/carcin/10.6.1003 10.1016/j.jep.2005.03.011 10.1186/1472-6882-12-149 |
| ContentType | Journal Article |
| Copyright | 2024. The Author(s). COPYRIGHT 2024 BioMed Central Ltd. 2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2024 |
| Copyright_xml | – notice: 2024. The Author(s). – notice: COPYRIGHT 2024 BioMed Central Ltd. – notice: 2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2024 |
| DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7TK 7U7 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR C1K CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PIMPY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
| DOI | 10.1186/s12906-024-04570-7 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Neurosciences Abstracts Toxicology Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials AUTh Library subscriptions: ProQuest Central Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Publicly Available Content (ProQuest) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Publicly Available Content Database Toxicology Abstracts ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) Neurosciences Abstracts ProQuest Central China ProQuest Hospital Collection (Alumni) Environmental Sciences and Pollution Management ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest One Academic ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE Publicly Available Content Database MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: http://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2662-7671 1472-6882 |
| EndPage | 14 |
| ExternalDocumentID | oai_doaj_org_article_eebd384049154122be9db7c5be532ccd A801484867 10_1186_s12906_024_04570_7 39010075 |
| Genre | Journal Article |
| GeographicLocations | Chile Asia Africa Latin America |
| GeographicLocations_xml | – name: Latin America – name: Asia – name: Africa – name: Chile |
| GrantInformation_xml | – fundername: Agencia Nacional de Investigación y Desarrollo grantid: 1230590 – fundername: Universidad de Valparaíso grantid: CIDI n°05/06 – fundername: Agencia Nacional de Investigación y Desarrollo grantid: 1210745 – fundername: Agencia Nacional de Investigación y Desarrollo grantid: 1130742 |
| GroupedDBID | 53G 7X7 88E 8FI 8FJ AAFWJ AAJSJ ABUWG ACRMQ ADUKV AFKRA AFPKN ALMA_UNASSIGNED_HOLDINGS BENPR BMC C24 C6C CCPQU CGR CUY CVF EBLON EBS ECM EIF EMB EMOBN FYUFA GROUPED_DOAJ HMCUK IAO IHR IHW INH ITC M1P M~E NPM PGMZT PIMPY PSQYO ROL RPM RSV SOJ SV3 UKHRP AAYXX CITATION AFGXO --- -A0 0R~ 23N 2WC 3V. 5VS 6J9 6PF 7TK 7U7 7XB 8FK A8Z AAHBH AAWTL ACGFO ACGFS ACMJI ACPRK ADBBV ADINQ ADRAZ AENEX AFRAH AHBYD AHMBA AHYZX ALIPV AMKLP AOIJS AZQEC BAWUL BCNDV BFQNJ BPHCQ BVXVI C1K CS3 DIK DU5 DWQXO E3Z F5P GX1 HYE INR K9. KQ8 O5R O5S OK1 P2P PQEST PQQKQ PQUKI PRINS PROAC RBZ RNS SMD TR2 UNMZH W2D WOQ WOW XSB 7X8 5PM |
| ID | FETCH-LOGICAL-c476t-aaaaed5bf32e0319d19000da4e8be8b0cb463563dd0af459845f201ddaf51e0b3 |
| IEDL.DBID | RPM |
| ISSN | 2662-7671 |
| IngestDate | Tue Oct 22 15:07:58 EDT 2024 Tue Sep 17 21:28:37 EDT 2024 Sat Oct 26 04:39:44 EDT 2024 Thu Oct 10 22:19:54 EDT 2024 Tue Nov 19 21:33:18 EST 2024 Tue Nov 12 23:36:37 EST 2024 Tue Aug 20 22:15:43 EDT 2024 Fri Nov 22 03:33:13 EST 2024 Sat Nov 02 12:18:26 EDT 2024 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Kalanchoe pinnata Chromatin condensation Ethanolic extract ROS Antioxidant Apoptosis Cancer |
| Language | English |
| License | 2024. The Author(s). Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c476t-aaaaed5bf32e0319d19000da4e8be8b0cb463563dd0af459845f201ddaf51e0b3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11247786/ |
| PMID | 39010075 |
| PQID | 3091289802 |
| PQPubID | 44230 |
| PageCount | 14 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_eebd384049154122be9db7c5be532ccd pubmedcentral_primary_oai_pubmedcentral_nih_gov_11247786 proquest_miscellaneous_3081291088 proquest_journals_3091289802 gale_infotracmisc_A801484867 gale_infotracacademiconefile_A801484867 gale_healthsolutions_A801484867 crossref_primary_10_1186_s12906_024_04570_7 pubmed_primary_39010075 |
| PublicationCentury | 2000 |
| PublicationDate | 2024-07-15 |
| PublicationDateYYYYMMDD | 2024-07-15 |
| PublicationDate_xml | – month: 07 year: 2024 text: 2024-07-15 day: 15 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: London |
| PublicationTitle | BMC complementary and alternative medicine |
| PublicationTitleAlternate | BMC Complement Med Ther |
| PublicationYear | 2024 |
| Publisher | BioMed Central Ltd BioMed Central BMC |
| Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
| References | ANB Singab (4570_CR33) 2011; 49 M Imran (4570_CR70) 2019; 33 A Koch (4570_CR51) 2005; 101 F Li (4570_CR10) 2013; 6 AR Hussain (4570_CR5) 2011; 50 EE Obaseiki-Ebor (4570_CR61) 1993; 302 4570_CR46 4570_CR44 N Nasim (4570_CR55) 2022; 65 CW Kim (4570_CR65) 2015; 29 4570_CR42 H Pelicano (4570_CR62) 2004; 7 EO Salami (4570_CR24) 2013; 6 L Liu (4570_CR9) 2019; 120 ML Willcox (4570_CR26) 2004; 329 4570_CR40 4570_CR41 4570_CR81 S Herrando-Moraira (4570_CR13) 2020; 10 T Yang (4570_CR47) 2002; 62 9 DEOFU Nnamdi (4570_CR25) 2011; 3 YK Mahmoud (4570_CR6) 2019; 115 H Kim (4570_CR68) 2012; 133 V Kuete (4570_CR16) 2017; 17 H Sung (4570_CR1) 2021; 71 G Marfe (4570_CR71) 2009; 106 EM Dergarabetian (4570_CR7) 2013; 5 JH Jeong (4570_CR78) 2009; 106 CA Lans (4570_CR23) 2006; 2 RP Adams (4570_CR48) 2007 4570_CR38 HC Huang (4570_CR19) 2013; 79 M Granato (4570_CR79) 2017; 41 4570_CR36 M Lopez-Lazaro (4570_CR50) 2015; 20 4570_CR34 A Bogucka-Kocka (4570_CR63) 2018; 25 MR Noori-Daloii (4570_CR76) 2011; 28 L Jia (4570_CR80) 2018; 208 T Kangsamaksin (4570_CR64) 2017; 12 YJ Hsieh (4570_CR31) 2012; 12 KY Kim (4570_CR72) 2016; 26 EA Cruz (4570_CR29) 2012; 19 PSM Celis-Pla (4570_CR45) 2018; 128 MX Ren (4570_CR74) 2015; 10 T Yamagishi (4570_CR60) 1989; 52 KR Park (4570_CR8) 2011; 312 4570_CR28 HH Aydin (4570_CR67) 2005; 43 YJ Hsieh (4570_CR15) 2016; 31 C Ferlini (4570_CR53) 2007; 2 4570_CR69 4570_CR22 LB Nascimento (4570_CR27) 2013; 89 R Singh (4570_CR52) 2019; 20 I Arias-Gonzalez (4570_CR32) 2018; 222 C Romay (4570_CR37) 1996; 29 S Kari (4570_CR54) 2022; 27 QT Majaz (4570_CR58) 2011; 2 P Singh (4570_CR73) 2021; 166 P Garcia-Perez (4570_CR56) 2019; 9 S Mahata (4570_CR18) 2012; 12 U Supratman (4570_CR20) 2001; 65 PL Wu (4570_CR21) 2006; 8 ZR Lai (4570_CR17) 2011; 39 S Ozsoy (4570_CR77) 2020; 20 RJ Ruch (4570_CR39) 1989; 10 6 4570_CR57 4570_CR14 4570_CR11 4570_CR12 4570_CR3 R Milad (4570_CR59) 2014; 4 R Santander (4570_CR43) 2013; 6 A Arvouet-Grand (4570_CR35) 1994; 49 C Kim (4570_CR2) 2018; 431 M Redza-Dutordoir (4570_CR4) 2016; 1863 J Manosroi (4570_CR49) 2006; 235 XH Deng (4570_CR75) 2013; 6 S Soltanian (4570_CR66) 2021; 73 ERD de Araujo (4570_CR30) 2019; 113 |
| References_xml | – volume: 62 9 start-page: 2583 year: 2002 ident: 4570_CR47 publication-title: J Cancer Res contributor: fullname: T Yang – volume: 43 start-page: 139 issue: 1 year: 2005 ident: 4570_CR67 publication-title: Food Chem Toxicol doi: 10.1016/j.fct.2004.09.003 contributor: fullname: HH Aydin – ident: 4570_CR12 doi: 10.3406/jobot.2006.2006 – volume: 4 start-page: 86 year: 2014 ident: 4570_CR59 publication-title: Eur J Med Plants doi: 10.9734/EJMP/2014/5901 contributor: fullname: R Milad – volume: 89 start-page: 391 issue: 2 year: 2013 ident: 4570_CR27 publication-title: Photochem Photobiol doi: 10.1111/php.12006 contributor: fullname: LB Nascimento – ident: 4570_CR40 – volume: 12 start-page: e0189628 issue: 12 year: 2017 ident: 4570_CR64 publication-title: PLoS ONE doi: 10.1371/journal.pone.0189628 contributor: fullname: T Kangsamaksin – volume: 49 start-page: 462 issue: 6 year: 1994 ident: 4570_CR35 publication-title: J Pharm Belg contributor: fullname: A Arvouet-Grand – volume: 312 start-page: 178 issue: 2 year: 2011 ident: 4570_CR8 publication-title: Cancer Lett doi: 10.1016/j.canlet.2011.08.001 contributor: fullname: KR Park – volume: 128 start-page: 214 year: 2018 ident: 4570_CR45 publication-title: Mar Pollut Bull doi: 10.1016/j.marpolbul.2018.01.005 contributor: fullname: PSM Celis-Pla – ident: 4570_CR69 doi: 10.3390/molecules24122277 – volume: 19 start-page: 115 issue: 2 year: 2012 ident: 4570_CR29 publication-title: Phytomedicine doi: 10.1016/j.phymed.2011.06.030 contributor: fullname: EA Cruz – ident: 4570_CR57 – volume: 10 start-page: 579 issue: 2 year: 2015 ident: 4570_CR74 publication-title: Exp Ther Med doi: 10.3892/etm.2015.2536 contributor: fullname: MX Ren – volume: 73 start-page: 1520 issue: 8 year: 2021 ident: 4570_CR66 publication-title: Nutr Cancer doi: 10.1080/01635581.2020.1795695 contributor: fullname: S Soltanian – volume: 106 start-page: 73 issue: 1 year: 2009 ident: 4570_CR78 publication-title: J Cell Biochem doi: 10.1002/jcb.21977 contributor: fullname: JH Jeong – volume: 329 start-page: 1156 issue: 7475 year: 2004 ident: 4570_CR26 publication-title: BMJ doi: 10.1136/bmj.329.7475.1156 contributor: fullname: ML Willcox – volume-title: Identification of Essential Oil Components by Gas Chromatography/Mass Spectrometry year: 2007 ident: 4570_CR48 contributor: fullname: RP Adams – volume: 2 start-page: 1478 year: 2011 ident: 4570_CR58 publication-title: IJRAP contributor: fullname: QT Majaz – volume: 26 start-page: 287 issue: 2 year: 2016 ident: 4570_CR72 publication-title: J Microbiol Biotechnol doi: 10.4014/jmb.1511.11054 contributor: fullname: KY Kim – volume: 65 start-page: 947 issue: 4 year: 2001 ident: 4570_CR20 publication-title: Biosci Biotechnol Biochem doi: 10.1271/bbb.65.947 contributor: fullname: U Supratman – volume: 3 start-page: 1 issue: 2 year: 2011 ident: 4570_CR25 publication-title: J Chem Pharm Res contributor: fullname: DEOFU Nnamdi – ident: 4570_CR36 doi: 10.4067/S0717-97072012000300022 – volume: 31 start-page: 1663 issue: 11 year: 2016 ident: 4570_CR15 publication-title: Environ Toxicol doi: 10.1002/tox.22170 contributor: fullname: YJ Hsieh – volume: 5 start-page: 706 issue: 2 year: 2013 ident: 4570_CR7 publication-title: Front Biosci (Elite Ed) doi: 10.2741/E651 contributor: fullname: EM Dergarabetian – ident: 4570_CR44 doi: 10.3390/molecules21111441 – volume: 431 start-page: 123 year: 2018 ident: 4570_CR2 publication-title: Cancer Lett doi: 10.1016/j.canlet.2018.05.038 contributor: fullname: C Kim – volume: 41 start-page: 124 year: 2017 ident: 4570_CR79 publication-title: J Nutr Biochem doi: 10.1016/j.jnutbio.2016.12.011 contributor: fullname: M Granato – volume: 71 start-page: 209 issue: 3 year: 2021 ident: 4570_CR1 publication-title: CA Cancer J Clin doi: 10.3322/caac.21660 contributor: fullname: H Sung – ident: 4570_CR22 – volume: 6 start-page: 3345 year: 2013 ident: 4570_CR43 publication-title: J Food Bioprocess Technol doi: 10.1007/s11947-012-0998-z contributor: fullname: R Santander – ident: 4570_CR28 doi: 10.3390/ijms19051265 – volume: 49 start-page: 1 year: 2011 ident: 4570_CR33 publication-title: J Bull Fac Pharm Cairo Univ contributor: fullname: ANB Singab – volume: 52 start-page: 1071 issue: 5 year: 1989 ident: 4570_CR60 publication-title: J Nat Prod doi: 10.1021/np50065a025 contributor: fullname: T Yamagishi – volume: 6 start-page: 843 issue: 8 year: 2013 ident: 4570_CR10 publication-title: Cancer Prev Res (Phila) doi: 10.1158/1940-6207.CAPR-13-0070 contributor: fullname: F Li – volume: 25 start-page: 622 issue: 4 year: 2018 ident: 4570_CR63 publication-title: Saudi J Biol Sci doi: 10.1016/j.sjbs.2016.01.037 contributor: fullname: A Bogucka-Kocka – ident: 4570_CR3 doi: 10.3390/ijms19020448 – volume: 12 start-page: 15 year: 2012 ident: 4570_CR18 publication-title: BMC Complement Altern Med doi: 10.1186/1472-6882-12-15 contributor: fullname: S Mahata – volume: 8 start-page: 5207 issue: 23 year: 2006 ident: 4570_CR21 publication-title: Org Lett doi: 10.1021/ol061873m contributor: fullname: PL Wu – volume: 39 start-page: 1275 issue: 6 year: 2011 ident: 4570_CR17 publication-title: Am J Chin Med doi: 10.1142/S0192415X1100955X contributor: fullname: ZR Lai – volume: 29 start-page: 1026 issue: 7 year: 2015 ident: 4570_CR65 publication-title: Phytother Res doi: 10.1002/ptr.5342 contributor: fullname: CW Kim – volume: 65 start-page: 399 issue: 3 year: 2022 ident: 4570_CR55 publication-title: Nucleus (Calcutta) doi: 10.1007/s13237-022-00405-3 contributor: fullname: N Nasim – volume: 208 start-page: 123 year: 2018 ident: 4570_CR80 publication-title: Life Sci doi: 10.1016/j.lfs.2018.07.027 contributor: fullname: L Jia – volume: 1863 start-page: 2977 issue: 12 year: 2016 ident: 4570_CR4 publication-title: Biochim Biophys Acta doi: 10.1016/j.bbamcr.2016.09.012 contributor: fullname: M Redza-Dutordoir – volume: 6 start-page: 1155 issue: 5 year: 2013 ident: 4570_CR75 publication-title: Exp Ther Med doi: 10.3892/etm.2013.1285 contributor: fullname: XH Deng – volume: 33 start-page: 263 issue: 2 year: 2019 ident: 4570_CR70 publication-title: Phytother Res doi: 10.1002/ptr.6227 contributor: fullname: M Imran – ident: 4570_CR42 – volume: 235 start-page: 114 issue: 1 year: 2006 ident: 4570_CR49 publication-title: Cancer Lett doi: 10.1016/j.canlet.2005.04.021 contributor: fullname: J Manosroi – volume: 10 start-page: 3143 issue: 1 year: 2020 ident: 4570_CR13 publication-title: Sci Rep doi: 10.1038/s41598-020-60079-2 contributor: fullname: S Herrando-Moraira – ident: 4570_CR46 doi: 10.1002/jlb.47.5.440 – volume: 28 start-page: 1395 issue: 4 year: 2011 ident: 4570_CR76 publication-title: Med Oncol doi: 10.1007/s12032-010-9603-3 contributor: fullname: MR Noori-Daloii – ident: 4570_CR41 doi: 10.3390/molecules26010067 – volume: 166 start-page: 10 year: 2021 ident: 4570_CR73 publication-title: Plant Physiol Biochem doi: 10.1016/j.plaphy.2021.05.023 contributor: fullname: P Singh – volume: 20 start-page: 1387 issue: 11 year: 2020 ident: 4570_CR77 publication-title: Anticancer Agents Med Chem doi: 10.2174/1871520620666200408082026 contributor: fullname: S Ozsoy – volume: 115 start-page: 108783 year: 2019 ident: 4570_CR6 publication-title: Biomed Pharmacother doi: 10.1016/j.biopha.2019.108783 contributor: fullname: YK Mahmoud – ident: 4570_CR38 doi: 10.1016/S0023-6438(95)80008-5 – volume: 9 start-page: 14830 issue: 1 year: 2019 ident: 4570_CR56 publication-title: Sci Rep doi: 10.1038/s41598-019-51322-6 contributor: fullname: P Garcia-Perez – volume: 79 start-page: 1362 issue: 14 year: 2013 ident: 4570_CR19 publication-title: Planta Med doi: 10.1055/s-0033-1350646 contributor: fullname: HC Huang – volume: 29 start-page: 175 issue: 2 year: 1996 ident: 4570_CR37 publication-title: Braz J Med Biol Res contributor: fullname: C Romay – volume: 133 start-page: 416 issue: 2 year: 2012 ident: 4570_CR68 publication-title: Food Chem doi: 10.1016/j.foodchem.2012.01.053 contributor: fullname: H Kim – volume: 27 start-page: 482 issue: 7–8 year: 2022 ident: 4570_CR54 publication-title: Apoptosis doi: 10.1007/s10495-022-01735-y contributor: fullname: S Kari – volume: 17 start-page: 280 issue: 1 year: 2017 ident: 4570_CR16 publication-title: BMC Complement Altern Med doi: 10.1186/s12906-017-1793-1 contributor: fullname: V Kuete – volume: 113 start-page: 108721 year: 2019 ident: 4570_CR30 publication-title: Biomed Pharmacother doi: 10.1016/j.biopha.2019.108721 contributor: fullname: ERD de Araujo – volume: 120 start-page: 4504 issue: 3 year: 2019 ident: 4570_CR9 publication-title: J Cell Biochem doi: 10.1002/jcb.27738 contributor: fullname: L Liu – ident: 4570_CR11 doi: 10.3390/metabo9110258 – volume: 106 start-page: 643 issue: 4 year: 2009 ident: 4570_CR71 publication-title: J Cell Biochem doi: 10.1002/jcb.22044 contributor: fullname: G Marfe – volume: 302 start-page: 109 issue: 2 year: 1993 ident: 4570_CR61 publication-title: Mutat Res doi: 10.1016/0165-7992(93)90012-K contributor: fullname: EE Obaseiki-Ebor – volume: 2 start-page: 3111 issue: 12 year: 2007 ident: 4570_CR53 publication-title: Nat Protoc doi: 10.1038/nprot.2007.397 contributor: fullname: C Ferlini – ident: 4570_CR81 doi: 10.1042/BSR20190720 – volume: 222 start-page: 133 year: 2018 ident: 4570_CR32 publication-title: J Ethnopharmacol doi: 10.1016/j.jep.2018.04.038 contributor: fullname: I Arias-Gonzalez – volume: 20 start-page: 167 issue: 2 year: 2015 ident: 4570_CR50 publication-title: Drug Discov Today doi: 10.1016/j.drudis.2014.12.006 contributor: fullname: M Lopez-Lazaro – volume: 7 start-page: 97 issue: 2 year: 2004 ident: 4570_CR62 publication-title: Drug Resist Updat doi: 10.1016/j.drup.2004.01.004 contributor: fullname: H Pelicano – volume: 2 start-page: 45 year: 2006 ident: 4570_CR23 publication-title: J Ethnobiol Ethnomed doi: 10.1186/1746-4269-2-45 contributor: fullname: CA Lans – volume: 50 start-page: 978 issue: 8 year: 2011 ident: 4570_CR5 publication-title: Free Radic Biol Med doi: 10.1016/j.freeradbiomed.2010.12.034 contributor: fullname: AR Hussain – ident: 4570_CR14 doi: 10.3390/molecules28145574 – volume: 20 start-page: 175 issue: 3 year: 2019 ident: 4570_CR52 publication-title: Nat Rev Mol Cell Biol doi: 10.1038/s41580-018-0089-8 contributor: fullname: R Singh – volume: 6 start-page: 421 issue: 6 year: 2013 ident: 4570_CR24 publication-title: Asian Pac J Trop Med doi: 10.1016/S1995-7645(13)60067-X contributor: fullname: EO Salami – ident: 4570_CR34 – volume: 10 6 start-page: 1003 year: 1989 ident: 4570_CR39 publication-title: J Carcinog doi: 10.1093/carcin/10.6.1003 contributor: fullname: RJ Ruch – volume: 101 start-page: 95 issue: 1–3 year: 2005 ident: 4570_CR51 publication-title: J Ethnopharmacol doi: 10.1016/j.jep.2005.03.011 contributor: fullname: A Koch – volume: 12 start-page: 149 year: 2012 ident: 4570_CR31 publication-title: BMC Complement Altern Med doi: 10.1186/1472-6882-12-149 contributor: fullname: YJ Hsieh |
| SSID | ssj0002313735 ssj0017814 |
| Score | 2.3136473 |
| Snippet | The leaves of Kalanchoe pinnata (Lam.) Pers. (K. pinnata), a succulent plant native to tropical regions, are used as a medicinal alternative against cancer in... Background The leaves of Kalanchoe pinnata (Lam.) Pers. (K. pinnata), a succulent plant native to tropical regions, are used as a medicinal alternative against... BackgroundThe leaves of Kalanchoe pinnata (Lam.) Pers. (K. pinnata), a succulent plant native to tropical regions, are used as a medicinal alternative against... Abstract Background The leaves of Kalanchoe pinnata (Lam.) Pers. (K. pinnata), a succulent plant native to tropical regions, are used as a medicinal... |
| SourceID | doaj pubmedcentral proquest gale crossref pubmed |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database |
| StartPage | 269 |
| SubjectTerms | Analysis Anthraquinones Antineoplastic Agents, Phytogenic - pharmacology Antioxidant Antioxidants Antioxidants - pharmacology Antitumor activity Apoptosis Apoptosis - drug effects Assaying Biochemistry Biocompatibility Calibration Cancer Care and treatment Caspase Cell cycle Cell death Cell Line, Tumor Cell proliferation Cell Proliferation - drug effects Cells Chromatin Chromatography Colon cancer Composition Cytotoxicity Enzymes Ergosterol Esters Ethanol Ethanolic extract Fatty acids Flavonoids Fragmentation Health aspects Humans Hydrogen peroxide In vitro methods and tests Isoflavones Kalanchoe - chemistry Kalanchoe pinnata Leaves Liquid chromatography Medicinal plants Medicine, Botanic Medicine, Herbal Membrane potential NMR Nuclear magnetic resonance Pharmaceuticals Phenolic compounds Phenols Phytochemicals Phytosterols Plant Extracts - chemistry Plant Extracts - pharmacology Plant Leaves - chemistry Quercetin Reactive Oxygen Species - metabolism Regression analysis Rhodamine ROS Scavenging Selectivity Stain Sterols Sulforhodamine Triacontanol Tropical environment Tropical environments Vitamin E |
| SummonAdditionalLinks | – databaseName: Directory of Open Access Journals dbid: DOA link: http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELagB8QFlXdKASMhAUJpk9iOvccCrSpRQKIgcbP8mKiLRHbVZP8Ov5UZJxttxIELqz2tJ9HGMx5_48x8w9hLcDUgkoi5K0KdS1FB7h06QyUrV9VVKEM6yj6_1J9_mA-nRJMztfqinLCBHniYuGMAHwVGIXKBm31ZVR4W0eugPChRhRCT9y3qnWDqZyJxKYUWalslY-rjjg5cKN-W8i6ULnI924kSYf_fbnlnX5rnTO5sQmf77M6IHvnJ8K_vshvQ3mO3Po3vx--z3x8pUxE9GvD1sm1d7_jrC_fr6A2nTPcjfgGu4UCn5UQHzNExU5EUp75Lfce71BMH3R_H6Sb3GOCaU-ED9ZfgY0cf_vXLZY6BPJpE5G69WvcrlOX0AoBHwpN82fLU-Y-Pd0hDhGa7B-z72em39-f52IEhD1LXfe7wA1H5BnVI5U6xpB6j0UkwHr9F8JL47USMhWukWhipGkQUMbpGlVB48ZDttasWHjMuBRjEXh40MQqGBuVdA8EULiyCjiJjb7fasOuBaMOmAMXUdtCdRd3ZpDurM_aOFDZJEkl2-gFNx46mY_9lOhl7Tuq2Q8XptNTtCTHqGKIizNirJEGLnRTixpoFfCSizZpJHs4kcZGG-fDWpOzoJDorEKthvGuKKmMvpmG6khLfWlhtSAYRGEI6YzL2aLDA6aHpuIogX8bMzDZnszIfaZdXiUIcUbYk5sCD_zGPT9jtKq0rnZfqkO311xt4ym52cfMsrco_LAs9-w priority: 102 providerName: Directory of Open Access Journals |
| Title | Kalanchoe pinnata (Lam.) Pers. Leaf ethanolic extract exerts selective anticancer activity through ROS-induced apoptotic cell death in human cancer cell lines |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/39010075 https://www.proquest.com/docview/3091289802 https://www.proquest.com/docview/3081291088 https://pubmed.ncbi.nlm.nih.gov/PMC11247786 https://doaj.org/article/eebd384049154122be9db7c5be532ccd |
| Volume | 24 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6RHhAXRHmalrBISICQE793cyylVVFbQBQkbqt9jCGI2Fbs_B1-KzMbO4rFjSin7DiKPTuz30xmvmHsJegCEEm4UEe2CLM0gdBodIZ5luikSGxsfSr74kZ8_C7fnxFNTjH0wviifWuWs-r3alYtf_raymZl50Od2Pzz9SlihIx4z-YTNkFwuBej__IELnEq0nzokEGxlpItVGtLNRe5iEIxOoU8Wf-_LnnvTBrXS-4dQOf32N0eOfKT7S88ZLegus9uX_f_jT9gfy6pShG9GfBmWVW60_z1lV7N3nCqcp_xK9AlB8qUExUwR6dMDVKcZi51LW_9PBx0fRwfNblGC2tOTQ80W4L303z4l083IQbxuB0c103ddDXKckr-c0dYki8r7qf-8f4b_BIh2fYh-3Z-9vX0IuynL4Q2E0UXanyBy02J-qNWJxfTfFGnM5AG35E1GXHbpc5FuszyhczyEtGEc7rMY4hM-ogdVHUFTxjPUpCIuwwIYhO0JcrrEqyMtF1Y4dKAvR20oZotyYbywYks1FZ3CnWnvO6UCNg7UthOkgiy_Qf1-ofqt4kCMC7F4DVbIEaMk8TAwhlhcwN5mljrAvac1K223aY7M1cnxKYjiYYwYK-8BBk6KUT3_Qp4S0SZNZI8Hkmigdrx8rClVO8gWpUiTsNYV0ZJwF7slulKKnqroN6QDKIvhHNSBuzxdgfubppSVQT3AiZHe3P0VMYraE2ePnywnqf_f-kRu5N4axJhnB-zg269gWds0rrNFMOSD5dTn9qYerv8CxCEPlM |
| link.rule.ids | 230,315,729,782,786,866,887,2106,27933,27934,53800,53802 |
| linkProvider | National Library of Medicine |
| linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEB7RIgEX3g9DoYuEBAg58dubYymtgpoURIvEbbWPMQQRJ4qTv8NvZWZjR7W4NcopM47izOzsN-uZbwDeoC6QkIQLdWSLMEsTDI2mYJhniU6KxMbWH2WPL8rzH_LTCdPkFF0vjC_at2Y2qP_MB_Xsl6-tXM7tsKsTG36dHhNGyJj3bLgHN2nBRtGVLP23p3CJ0zLNux4ZUmz4uIWrbbnqIi-jsOztQ56u__-gfGVX6ldMXtmCTu9d98ffh7st6BRHW_kDuIH1Q7g1bR-rP4K_Z1zgSIEQxXJW13qtxbuJng_eCy6QH4gJ6kogH7Izi7CgeM69VYLHNa0b0fhROhQ1BVmJo6rFleB-CR5LIdpBQOLbl4uQ8n_yJCf0crFcL0hX8HMD4RiGilkt_MBA0X6DFzEIbh7D99OTy-Nx2A5uCG1WFutQ0wtdbioyPXdJuZhHkzqdoTT0jqzJmBYvdS7SVZaPZJZXBESc01UeY2TSJ7BfL2p8BiJLURJkM1gyEaGtSF9XaGWk7ciWLg3gQ2dGtdzycyif18hCbY2uyOjKG12VAXxkS-80mVvbf7BY_VStkRSicSnlvdmI4GWcJAZHzpQ2N5inibUugEP2E7VtVN1FCHXERDySGQwDeOs1OEawQXTb6kC3xGxbPc2DniatbdsXd76o2tjSqJQgHqXJMkoCeL0T85VcL1fjYsM6BNwICUoZwNOt6-5umk-5GCkGIHtO3ftX-hLyZc883vnu8-tfegi3x5fTiZp8Pj97AXcSvyTLMM4PYH-92uBL2Gvc5pVf0P8APHVSIg |
| linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9NAEB7RIlVceD8MhS4SEiDkxM_Y4VbaRkVNS0VB4rbax7gNIo4VO3-H38rMxo5icQPLJ-_Y0npmZ7_dnfkG4A2qERKSsL4KzMhP4gh9rcgZpkmkolFkQuO2sk-vsosf-fEJ0-R87HJhXNC-0bNB-Ws-KGc3LraympthFyc2vDw_IoyQMO_ZsLLFcAdu06ANoq2V-k9H4xLGWZx2eTIkXPOWC0fccuRFmgV-1puLHGX_3455a2bqR01uTUOTe__TgftwtwWf4nAt8wBuYfkQ9s7b4_VH8PuMAx3JIaKoZmWpGiXeTdV88F5woPxATFEVAnmzndmEBfl1zrESXLapqUXtSuqQ9xSkLfauBpeC8ya4PIVoCwKJr1-u_FlpyaKsUNWiahYkK_j8QFiGo2JWClc4ULRfcE0MhuvH8H1y8u3o1G8LOPgmyUaNr-hCm-qCTICzpWzIJUqtSjDXdAdGJ0yPF1sbqCJJx3mSFgRIrFVFGmKg4yewWy5KfAYiiTEn6KYxY0JCU5C8KtDkgTJjk9nYgw-dKmW15umQbn2Tj-Ra8ZIUL53iZebBJ9b2RpI5tt2DxfJatoqSiNrGtP5NxgQzwyjSOLY6M6nGNI6MsR4csK3IdcLqxlPIQybkyZnJ0IO3ToJ9BStEtSkP1CVm3epJ7vckaYybfnNnj7L1MbWMCerRcplM34PXm2Z-k-PmSlysWIYAHCHCPPfg6dp8N53m3S5GjB7kPcPu_ZV-C9mzYyDv7Pf5v796AHuXxxM5_Xxx9gLuRG5UZn6Y7sNus1zhS9ip7eqVG9N_AK0RVKI |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Kalanchoe+pinnata+%28Lam.%29+Pers.+Leaf+ethanolic+extract+exerts+selective+anticancer+activity+through+ROS-induced+apoptotic+cell+death+in+human+cancer+cell+lines&rft.jtitle=BMC+complementary+medicine+and+therapies&rft.au=Faundes-Gandolfo%2C+Nicolas&rft.au=Jara-Guti%C3%A9rrez%2C+Carlos&rft.au=P%C3%A1rraga%2C+Mario&rft.au=Montenegro%2C+Iv%C3%A1n&rft.date=2024-07-15&rft.issn=2662-7671&rft.eissn=2662-7671&rft.volume=24&rft.issue=1&rft.spage=269&rft_id=info:doi/10.1186%2Fs12906-024-04570-7&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2662-7671&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2662-7671&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2662-7671&client=summon |